If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

The booster shot – called mRNA-1273.211 – offered better and longer-lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including the prevailing Omicron ...

1 than the original Spikevax. The 437-patient study – reported in June – compared a 50 µg booster dose of both vaccines on antibody levels one month after administration, with the new version ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Yes, older Americans should get yet another COVID shot—but if you have already gotten the latest version, there's no rush.

The fall booster shot will protect against some of the latest strains of the virus, including JN. 1 and KP. 2, Health Canada ...

Fewer health care workers are getting the most recent COVID-19 booster. Findings from a new survey by the ... On top of this, ...

Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tyler Van Buren ...

These mRNA vaccines use genetic instructions ... from 19 individuals over 28 days after receiving a Moderna SPIKEVAX mRNA booster immunisation. The team discovered key insights into the movement ...